Conexeu Sciences Inc.

Conexeu Sciences Inc.

CNXU · Nasdaq

Conexeu Sciences Inc. (CNXU) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Conexeu Sciences Inc. in 2026. The next earnings report is expected on September 30, 2026.

Earnings calendar

Next earnings date

30 Sep 2026

In 40 days

EPS estimate

-0.10

Revenue estimate

0

Past earnings

15 Jun 2026
EPS actual
-0.11 (0.0%)
estimate -0.11
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Conexeu Sciences Inc. met consensus estimates in its latest earnings report, with EPS of USD -0.11 matching expectations and revenue of USD 0 meeting estimates. No prior report data is available for comparison.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Miles Harrison
Employees
4
IPO date
21 May 2026
ISIN
US20715F1003
Website
conexeu.com

Frequently asked questions

When does Conexeu Sciences Inc. (CNXU) next report earnings?

Conexeu Sciences Inc. (CNXU) is scheduled to report earnings on September 30, 2026.

What was Conexeu Sciences Inc.'s most recent earnings date?

Conexeu Sciences Inc. (CNXU) last reported earnings on June 15, 2026.

Where is Conexeu Sciences Inc. stock listed?

Conexeu Sciences Inc. (CNXU) is listed on Nasdaq.